Page 544 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

522 PART IV Specific Malignancies in the Small Animal Patient

331. Burgess HJ, Kerr ME: Cytokeratin and vimentin co-expression in 353. Poirier VJ, Burgess KE, Adams WM, et al.: Toxicity, dosage, and
21 canine primary pulmonary epithelial neoplasms, J Vet Diagn efficacy of vinorelbine (Navelbine) in dogs with spontaneous neo-
Invest 21:815–820, 2009. plasia, J Vet Intern Med 18:536–539, 2004.
VetBooks.ir 332. Beck J, Miller MA, Frank C, et al.: Surfactant protein A and napsin 354. Chabner B, Longo DL: Cancer chemotherapy and biotherapy: prin-
ciples and practice, ed 4, Philadelphia, 2006, Lippincott Williams &
A in the immunohistochemical characterization of canine pulmo-
nary carcinomas: comparison with thyroid transcription factor-1,
Wilkins.
Vet Pathol 54:767–774, 2017. 355. Skorupski KA, Rodriguez CO, Krick EL, et al.: Long-term survival
333. Affolter VK, Moore PF: Localized and disseminated histio- in dogs with localized histiocytic sarcoma treated with CCNU as an
cytic sarcoma of dendritic cell origin in dogs, Vet Pathol 39: adjuvant to local therapy, Vet Comp Oncol 7:139–144, 2009.
74–83, 2002. 356. Hershey AE, Kurzman ID, Forrest LJ, et al.: Inhalation chemo-
334. Kato Y, Murakami M, Hoshino Y, et al.: The class A macrophage therapy for macroscopic primary or metastatic lung tumors: proof
scavenger receptor CD204 is a useful immunohistochemical of principle using dogs with spontaneously occurring tumors as a
marker of canine histiocytic sarcoma, J Comp Pathol 148:188–196, model, Clin Cancer Res 5:2653–2659, 1999.
2013. 357. Khanna C, Vail DM: Targeting the lung: preclinical and compara-
335. Moore PF: A review of histiocytic diseases of dogs and cats, Vet tive evaluation of anticancer aerosols in dogs with naturally occur-
Pathol 51:167–184, 2014. ring cancers, Curr Cancer Drug Targets 3:265–273, 2003.
336. Slatter DH, editor: Textbook of small animal surgery, ed 3, Philadel- 358. London CA, Hannah AL, Zadovoskaya R, et al.: Phase I dose-esca-
phia, PA, 2003, Saunders. lating study of SU11654, a small molecule receptor tyrosine kinase
337. LaRue SM, Withrow SJ, Wykes PM: Lung resection using surgical inhibitor, in dogs with spontaneous malignancies, Clin Cancer Res
staples in dogs and cats, Vet Surg 16:238–240, 1987. 9:2755–2768, 2003.
338. Walshaw R: Stapling techniques in pulmonary surgery, Vet Clin 359. Moore AS, Kirk C, Cardona A: Intracavitary cisplatin chemother-
North Am Small Anim Pract 24:335–366, 1994. apy experience with six dogs, J Vet Intern Med 5:227–231, 1991.
339. Wavreille V, Boston SE, Souza C, et al.: Outcome after pneumo- 360. Spugnini EP, Crispi S, Scarabello A, et al.: Piroxicam and intracavi-
nectomy in 17 dogs and 10 cats: a Veterinary Society of Surgical tary platinum-based chemotherapy for the treatment of advanced
Oncology case series, Vet Surg 45:782–789, 2016. mesothelioma in pets: preliminary observations, J Exp Clin Cancer
340. Majeski SA, Steffey MA, Mayhew PD, et al.: Postoperative respira- Res 27:6, 2008.
tory function and survival after pneumonectomy in dogs and cats, 361. Kelly J, Holmes EC, Rosen G: Mitoxantrone for malignant pleural
Vet Surg 45:775–781, 2016. effusion due to metastatic sarcoma, Surg Oncol 2:299–301, 1993.
341. Lansdowne JL, Monnet E, Twedt DC, et al.: Thoracoscopic lung 362. Sparkes A, Murphy S, McConnell F, et al.: Palliative intracavitary
lobectomy for treatment of lung tumors in dogs, Vet Surg 34:530– carboplatin therapy in a cat with suspected pleural mesothelioma,
535, 2005. J Feline Med Surg 7:313–316, 2005.
342. Levionnois OL, Bergadano A, Schatzmann U: Accidental entrap- 363. Laing EJNA: Pleurodesis as a treatment for pleural effusion in the
ment of an endo-bronchial blocker tip by a surgical stapler during dog, J Am Anim Hosp Assoc 2(4), 1986.
selective ventilation for lung lobectomy in a dog, Vet Surg 35:82– 364. Li R, Yu L, Lin S, et al.: Involved field radiotherapy (IFRT) versus
85, 2006. elective nodal irradiation (ENI) for locally advanced non-small cell
343. Dhumeaux MP, Haudiquet PR: Primary pulmonary osteosarcoma lung cancer: a meta-analysis of incidence of elective nodal failure
treated by thoracoscopy-assisted lung resection in a dog, Can Vet J (ENF), Radiat Oncol 11:124, 2016.
50:755–758, 2009. 365. Rose SC, Thistlethwaite PA, Sewell PE, et al.: Lung cancer and
344. Bleakley S, Duncan CG, Monnet E: Thoracoscopic lung lobectomy radiofrequency ablation, J Vasc Interv Radiol 17:927–951, 2006.
for primary lung tumors in 13 dogs, Vet Surg 44:1029–1035, 2015. 366. Okuma T, Matsuoka T, Yamamoto A, et al.: Frequency and risk
345. Mayhew PD, Hunt GB, Steffey MA, et al.: Evaluation of short-term factors of various complications after computed tomography-
outcome after lung lobectomy for resection of primary lung tumors guided radiofrequency ablation of lung tumors, Cardiovasc Inter-
via video-assisted thoracoscopic surgery or open thoracotomy in vent Radiol 31:122–130, 2008.
medium- to large-breed dogs, J Am Vet Med Assoc 243:681–688, 367. Crocetti L, Lencioni R: Radiofrequency ablation of pulmonary
2013. tumors, Eur J Radiol 75:23–27, 2010.
346. Mosing M, Iff I, Moens Y: Endoscopic removal of a bronchial car- 368. Duncan M, Wijesekera N, Padley S: Interventional radiology of the
cinoma in a dog using one-lung ventilation, Vet Surg 37:222–225, thorax, Respirology 15:401–412, 2010.
2008. 369. Grootenboers MJ, Schramel FM, van Boven WJ, et al.: Selective
347. Mayhew PD, Pascoe PJ, Shilo-Benjamini Y, et al.: Effect of one- pulmonary artery perfusion followed by blood flow occlusion: new
lung ventilation with or without low-pressure carbon dioxide challenge for the treatment of pulmonary malignancies, Lung Can-
insufflation on cardiorespiratory variables in cats undergoing tho- cer 63:400–404, 2009.
racoscopy, Vet Surg 44:O15–O22, 2015. 370. Ahrar K, Price RE, Wallace MJ, et al.: Percutaneous radiofrequency
348. Denlinger CE, Fernandez F, Meyers BF, et al.: Lymph node evalu- ablation of lung tumors in a large animal model, J Vasc Interv Radiol
ation in video-assisted thoracoscopic lobectomy versus lobectomy 14:1037–1043, 2003.
by thoracotomy, Ann Thorac Surg 89:1730–1735, 2010. 371. Muller H, Guadagni S: Regional chemotherapy for carcinoma of
349. Steffey MA, Daniel L, Mayhew PD, et al.: Video-assisted thoraco- the lung, Surg Oncol Clin North Am 17:895–991, 2008.
scopic extirpation of the tracheobronchial lymph nodes in dogs, Vet 372. van Putte BP, Grootenboers M, van Boven WJ, et al.: Selective
Surg 44:O50–O58, 2015. pulmonary artery perfusion for the treatment of primary lung can-
350. DeVita VT, Lawrence TS, Rosenberg SA: Devita, hellman, and cer: improved drug exposure of the lung, Lung Cancer 65:208–213,
rosenberg’s cancer: principles & practice of oncolog, 8th ed, Philadel- 2009.
phia, 2008, Wolters Kluwer/Lippincott Williams & Wilkins. 373. Ogilvie GK, Weigel RM, Haschek WM, et al.: Prognostic factors
351. Ogilvie GK, Reynolds HA, Richardson RC, et al.: Phase II evalu- for tumor remission and survival in dogs after surgery for primary
ation of doxorubicin for treatment of various canine neoplasms, lung tumor: 76 cases (1975-1985), J Am Vet Med Assoc 195:109–
J Am Vet Med Assoc 195:1580–1583, 1989. 112, 1989.
352. Ogilvie GK, Obradovich JE, Elmslie RE, et al.: Efficacy of mito- 374. Polton GA, Brearley MJ, Powell SM, et al.: Impact of primary
xantrone against various neoplasms in dogs, J Am Vet Med Assoc tumour stage on survival in dogs with solitary lung tumours,
198:1618–1621, 1991. J Small Anim Pract 49:66–71, 2008.